홈 › 만성 폐쇄성 폐질환 › 텍사스 › Dallas
TX Dallas의 만성 폐쇄성 폐질환 임상 시험
만성 폐쇄성 폐질환 관련 연구 12개가 Dallas 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
피험자 모집 중3상
- Texas Health Presbyterian Hospital Dallas- Site Number : 8400032, Dallas
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
피험자 모집 중
- University of Texas Southwestern, Dallas
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
피험자 모집 중3상
- IntraCare- Site Number : 8400034, Dallas
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
피험자 모집 중2상
- Research Site, Dallas
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
피험자 모집 중3상
- Research Site, Dallas
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
피험자 모집 중2/3상
- Alina Clinical Trials, LLC., Dallas
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
피험자 모집 중3상
- Research Site, Dallas
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
피험자 모집 중3상
- GC2501 Study Site 109, Dallas
STRIVE Post-Market Registry Study
피험자 모집 중관찰 연구
- Baylor Scott & White Research Institute, Dallas
- University of Texas Southwestern, Dallas
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
피험자 모집 중3상
- GSK Investigational Site, Dallas
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
피험자 모집 중관찰 연구
- Liver Center of Texas, Dallas
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
피험자 모집 중3상
- GSK Investigational Site, Dallas
다른 도시의 만성 폐쇄성 폐질환 시험
- Philadelphia, PA연구 22개
- Miami, FL연구 18개
- Birmingham, AL연구 18개
- Boston, MA연구 17개
- Houston, TX연구 15개
- Orlando, FL연구 15개
- Chicago, IL연구 14개
- Baltimore, MD연구 13개
- Pittsburgh, PA연구 13개
- New York City, NY연구 11개
- Ann Arbor, MI연구 10개
- Winston-Salem, NC연구 9개
Dallas의 다른 연구
- 유방암연구 54개
- 비소세포폐암연구 52개
- 심부전연구 43개
- 전이성 암연구 42개
- 암 (전체)연구 38개
- 전립선암연구 36개
- 대장직장암연구 33개
- 비만연구 31개
- 난소암연구 28개
- 폐암연구 27개
- 방광암연구 27개
- 자궁내막암연구 25개
ClinicalTrials.gov 출처, 2026. 9. 29. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.